Skip to main content

Mozobil Prices, Coupons and Patient Assistance Programs

Mozobil (plerixafor) is a member of the hematopoietic stem cell mobilizer drug class and is commonly used for Hematopoietic Stem Cell Mobilization, Multiple Myeloma, and Non-Hodgkin's Lymphoma.

The cost for Mozobil subcutaneous solution (20 mg/mL) is around $10,506 for a supply of 1.2 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

A generic version of Mozobil is available. See plerixafor prices (from $519.50 for 1.2 milliliters).

Mozobil prices

Subcutaneous Solution

Quantity Per unit Price
1.2 milliliters $8,754.89 $10,505.87

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Mozobil Coupons, Copay Cards and Rebates

Mozobil offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

No manufacturer promotions could be found for this medication.

Patient Assistance & Copay Programs for Mozobil

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Sanofi Patient Connection

Eligibility requirements:
  1. Must have no prescription coverage for needed medication
  2. At or below 400% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must be residing in the US or a US territory, and under the care of a US physician
  5. Healthcare provider must contact the Program for REORDER FORMS. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
Applicable drugs:
  • Mozobil (plerixafor) Injection; Subcutaneous

More information please phone: 888-847-4877 Visit Website

Provider: HealthWell Foundation Copay Program

Eligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Mozobil (plerixafor) Injection; Subcutaneous

More information please phone: 800-675-8416 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.